274 related articles for article (PubMed ID: 33021063)
1. Impaired insulin secretion predicting unstable glycemic variability and time below range in type 2 diabetes patients regardless of glycated hemoglobin or diabetes treatment.
Miya A; Nakamura A; Handa T; Nomoto H; Kameda H; Cho KY; Nagai S; Miyoshi H; Atsumi T
J Diabetes Investig; 2021 May; 12(5):738-746. PubMed ID: 33021063
[TBL] [Abstract][Full Text] [Related]
2. Defining the target value of the coefficient of variation by continuous glucose monitoring in Chinese people with diabetes.
Mo Y; Ma X; Lu J; Shen Y; Wang Y; Zhang L; Lu W; Zhu W; Bao Y; Zhou J
J Diabetes Investig; 2021 Jun; 12(6):1025-1034. PubMed ID: 33119969
[TBL] [Abstract][Full Text] [Related]
3. Defining High Glycemic Variability in Type 1 Diabetes: Comparison of Multiple Indexes to Identify Patients at Risk of Hypoglycemia.
Gómez AM; Henao DC; Imitola Madero A; Taboada LB; Cruz V; Robledo Gómez MA; Rondón M; Muñoz-Velandia O; García-Jaramillo M; León Vargas FM
Diabetes Technol Ther; 2019 Aug; 21(8):430-439. PubMed ID: 31219350
[No Abstract] [Full Text] [Related]
4. Study of Glycemic Variability in Well-controlled Type 2 Diabetic Patients Using Continuous Glucose Monitoring System.
Swami V; Yadav SK; Saxena P; Sharma A; Dash CK; Gupta A
J Assoc Physicians India; 2024 Jan; 72(1):18-21. PubMed ID: 38736069
[TBL] [Abstract][Full Text] [Related]
5. Log-linear relationship between endogenous insulin secretion and glycemic variability in patients with type 2 diabetes on continuous glucose monitoring.
Miya A; Nakamura A; Handa T; Nomoto H; Kameda H; Cho KY; Nagai S; Ito YM; Miyoshi H; Atsumi T
Sci Rep; 2021 Apr; 11(1):9057. PubMed ID: 33907279
[TBL] [Abstract][Full Text] [Related]
6. The different methods of assessing glycemic variability, quality of glycemic control and glycemic risk cannot be interpreted as equivalent in clinical practice.
Muñoz OM; Gómez AM; Maira GJ; Fabián Mauricio LV; Ruiz-Morales ÁJ
Diabetes Metab Syndr; 2018 Jul; 12(4):555-561. PubMed ID: 29631779
[TBL] [Abstract][Full Text] [Related]
7. Beyond HbA1c: Comparing Glycemic Variability and Glycemic Indices in Predicting Hypoglycemia in Type 1 and Type 2 Diabetes.
Rama Chandran S; Tay WL; Lye WK; Lim LL; Ratnasingam J; Tan ATB; Gardner DSL
Diabetes Technol Ther; 2018 May; 20(5):353-362. PubMed ID: 29688755
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity of Traditional and Risk-Based Glycemic Variability Measures to the Effect of Glucose-Lowering Treatment in Type 2 Diabetes Mellitus.
Kovatchev B; Umpierrez G; DiGenio A; Zhou R; Inzucchi SE
J Diabetes Sci Technol; 2015 Jun; 9(6):1227-35. PubMed ID: 26078255
[TBL] [Abstract][Full Text] [Related]
9. Optimal Coefficient of Variance Threshold to Minimize Hypoglycemia Risk in Individuals with Well-Controlled Type 1 Diabetes Mellitus.
Yoo JH; Yang SH; Jin SM; Kim JH
Diabetes Metab J; 2024 May; 48(3):429-439. PubMed ID: 38476023
[TBL] [Abstract][Full Text] [Related]
10. The effect of glycemic variability on counterregulatory hormone responses to hypoglycemia in young children and adolescents with type 1 diabetes.
Alghothani N; Dungan KM
Diabetes Technol Ther; 2011 Nov; 13(11):1085-9. PubMed ID: 21770764
[TBL] [Abstract][Full Text] [Related]
11. Effect of Education on Impaired Hypoglycemia Awareness and Glycemic Variability in Children and Adolescents with Type 1 Diabetes Mellitus.
Demir G; Özen S; Çetin H; Darcan Ş; Gökşen D
J Clin Res Pediatr Endocrinol; 2019 May; 11(2):189-195. PubMed ID: 30701953
[TBL] [Abstract][Full Text] [Related]
12. Relation Between Hypoglycemia and Glycemic Variability in Type 2 Diabetes Patients with Insulin Therapy: A Study Based on Continuous Glucose Monitoring.
Uemura F; Okada Y; Torimoto K; Tanaka Y
Diabetes Technol Ther; 2018 Feb; 20(2):140-146. PubMed ID: 29293363
[TBL] [Abstract][Full Text] [Related]
13. Risk Factor Analysis for Type 2 Diabetes Patients About Hypoglycemia Using Continuous Glucose Monitoring: Results from a Prospective Observational Study.
Uemura F; Okada Y; Mita T; Torimoto K; Wakasugi S; Katakami N; Yoshii H; Matsushita K; Nishida K; Inokuchi N; Tanaka Y; Gosho M; Shimomura I; Watada H
Diabetes Technol Ther; 2022 Jun; 24(6):435-445. PubMed ID: 35049378
[No Abstract] [Full Text] [Related]
14. Short-term recovery of insulin secretion in response to a meal is associated with future glycemic control in type 2 diabetes patients.
Enkaku A; Chujo D; Kamigishi M; Inagawa S; Matsukoshi S; Sakai W; Takikawa A; Fujisaka S; Tobe K
J Diabetes Investig; 2024 Apr; 15(4):437-448. PubMed ID: 38151917
[TBL] [Abstract][Full Text] [Related]
15. Respective Contributions of Glycemic Variability and Mean Daily Glucose as Predictors of Hypoglycemia in Type 1 Diabetes: Are They Equivalent?
Monnier L; Wojtusciszyn A; Molinari N; Colette C; Renard E; Owens D
Diabetes Care; 2020 Apr; 43(4):821-827. PubMed ID: 31988062
[TBL] [Abstract][Full Text] [Related]
16. Clinical factors associated with absolute and relative measures of glycemic variability determined by continuous glucose monitoring: an analysis of 480 subjects.
Jin SM; Kim TH; Bae JC; Hur KY; Lee MS; Lee MK; Kim JH
Diabetes Res Clin Pract; 2014 May; 104(2):266-72. PubMed ID: 24630619
[TBL] [Abstract][Full Text] [Related]
17. A1c, glucose variability and hypoglycemia risk in patients with type 1 diabetes.
Guelho D; Paiva I; Batista C; Barros L; Carrilho F
Minerva Endocrinol; 2014 Jun; 39(2):127-33. PubMed ID: 24736487
[TBL] [Abstract][Full Text] [Related]
18. Glycemic variability assessed by continuous glucose monitoring and the risk of diabetic retinopathy in latent autoimmune diabetes of the adult and type 2 diabetes.
Lu J; Ma X; Zhang L; Mo Y; Ying L; Lu W; Zhu W; Bao Y; Zhou J
J Diabetes Investig; 2019 May; 10(3):753-759. PubMed ID: 30306722
[TBL] [Abstract][Full Text] [Related]
19. Lixisenatide reduces glycaemic variability in insulin-treated patients with type 2 diabetes.
Umpierrez GE; O'Neal D; DiGenio A; Goldenberg R; Hernandez-Triana E; Lin J; Park CY; Renard E; Kovatchev B
Diabetes Obes Metab; 2017 Sep; 19(9):1317-1321. PubMed ID: 28256054
[TBL] [Abstract][Full Text] [Related]
20. Hypoglycemia in patients with type 2 diabetes treated with oral antihyperglycemic agents detected by continuous glucose monitoring: a multi-center prospective observational study in Croatia.
Baretić M; Bralić Lang V
BMC Endocr Disord; 2020 Mar; 20(1):35. PubMed ID: 32151247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
